Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03994770 · ClinicalTrials.gov registry record · NA

An Engineering-Based Balance Assessment and Training Platform

A NA study of Stroke and Balance Deficits, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT03994770: Completed NA study of Stroke and Balance Deficits, sponsored by VA Office of Research and Development.

NCT03994770 is a NA study of Stroke and Balance Deficits that has completed, run by VA Office of Research and Development. The registered enrollment target is 7 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03994770, a NA study of Stroke and Balance Deficits, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

This is a proposal to develop a Balanced Reach Training Protocol (BRTP) to evaluate and train dynamic standing balance. The BRTP is based upon the Balanced Reach Test (BRT) that the investigators previously developed and validated. In the BRT subjects stand and point to a target disk moving unpredictably across a large projection screen in front of them without stepping. Body movements undertaken to track the disk are integral to many daily activities and represent an important class of "expected" balance disturbances that can precipitate falls. The BRTP employs engineering and psychophysical methods, and exploits advances in real time computing in a novel and innovative way to more effectively evaluate and train balance function. The BRTP presents a challenging reaching/tracking task that subjects perform at their limit of balance. The BRTP is an objective, quantitative test that can evaluate balance function without floor or ceiling effects, and train balance across the spectrum of aging, disease, and injury.

Primary Outcome

Measure of Balance Capability. Root Mean Squared Deviation (RMSD) records the root mean squared distance between the ground plane projection of whole-body Center of Mass and the center of the Base of Support during performance of the balanced reach task, in centimeters. It ranges from zero to the distance from the center of the Base of Support to the boundary of the Base of Support. Larger deviations indicate better performance than smaller deviations.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Balanced Reach Assessment and Training Protocol

Study Locations (1)

Maryland

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2021-11-15
Est. Completion 2023-12-12
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03994770 record still lists

NCT03994770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Balanced Reach Assessment and Training Protocol is the first listed.

NCT03994770 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT03994770 about?

NCT03994770 is a clinical study titled "An Engineering-Based Balance Assessment and Training Platform". This is a proposal to develop a Balanced Reach Training Protocol (BRTP) to evaluate and train dynamic standing balance. The BRTP is based upon the Balanced Reach Test (BRT) that the investigators previously developed and validated. In the BRT subjects stand and point to a target disk moving unpredic...

What is the current status of trial NCT03994770?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-11-15. Estimated completion is 2023-12-12.

What conditions does trial NCT03994770 study?

This clinical trial studies the following conditions: Stroke, Balance Deficits.

What interventions are being tested in trial NCT03994770?

The interventions under investigation include: Balanced Reach Assessment and Training Protocol (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03994770?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03994770 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03994770's enrollment target sits among peer trials

7 430th of 454 higher than 23 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03994770, the US trial registry maintained by the National Library of Medicine. NCT03994770 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.